Drugs & Programmes
Clear views of assets and development programmes, designed to distinguish the drug itself from the indications, geographies, companies and statuses around it.
DDI Signal Drugs
Drug development intelligence.
Structured pharmaceutical intelligence designed to make complex drug, pipeline and competitive landscapes clearer, more comparable and more useful for decision-making.
Why DDI Signal Drugs
Drug development data is abundant. Clarity is rare.
Pharmaceutical pipelines are complex, fast-moving and difficult to compare consistently. More data does not automatically create better intelligence.
DDI Signal Drugs is built around structured, decision-relevant pharmaceutical intelligence: organising drug development information so that important differences, relationships and competitive signals are easier to understand.
What matters
Structure before volume.
Pipelines & Landscapes
Structured intelligence for understanding how therapeutic, modality and competitive landscapes are evolving over time.
Targets & Mechanisms
Consistent treatment of targets, target families and mechanisms to support meaningful comparison across development programmes.
Competitive Signal
Intelligence designed to surface what is strategically relevant rather than simply reproduce the volume of available information.
Our principles
Designed around the decision.
Clarity
Clarity over completeness.
Structure
Structure over sprawl.
Signal
Insight over volume.
Connected intelligence
From landscape to strategic implication.
DDI Signal Drugs and DDI Signal Consulting are complementary capabilities. Structured drug development intelligence provides the evidence base; strategic analysis helps translate that evidence into implications for portfolios, competitors and decisions.
DDI Signal Drugs
Need a clearer view of the landscape?
Tell us what you are trying to understand. We can discuss how DDI Signal's drug development intelligence can support the question.